101. Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
- Author
-
Yuli Lily Hsieh, Summer Rak, Gillian K SteelFisher, and Sebastian Bauhoff
- Subjects
Adult ,Vaccine safety ,COVID-19 Vaccines ,General Veterinary ,General Immunology and Microbiology ,SARS-CoV-2 ,Short Communication ,Vaccination ,Public Health, Environmental and Occupational Health ,COVID-19 ,United States ,Infectious Diseases ,Humans ,Molecular Medicine ,Vaccination Hesitancy ,Vaccine hesitancy ,USA - Abstract
On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended “a pause in the use of this vaccine out of an abundance of caution.” We examined whether public attitudes toward COVID-19 vaccination shifted after this recommended suspension using an interrupted time series with data from the Census Bureau’s Household Pulse Survey, which was fielded bi-weekly between January 6 and April 26, 2021. We found no significant changes in trends of the proportion of the U.S. adult population hesitant about getting a COVID-19 vaccine, but a significant increase in concerns about safety and efficacy of COVID-19 vaccines among the already hesitant population.
- Published
- 2022